Psychiatry and Neurology, Neurology · Livingston, NJ
NPI
1780788992
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
200 S Orange Ave, Ste 200
Livingston, NJ, 07039
Phone (973) 322-7580
Groups this clinician bills Medicare through
Medicare paid, 2024
$284K
2,266 services
Medicare patients, 2024
685
Average age 66
Drug cost, 2024
$3.2M
8,437 prescriptions
Company payments, 2025
$453
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eric B Geller was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 472 times for 301 patients. In total Eric B Geller billed 2,266 services in 40 codes, and Medicare paid $284K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 472 | 301 | $14.33 | $6,764 |
| 99214 Office E&M - Established | Office | 251 | 185 | $108.25 | $27K |
| 99215 Office E&M - Established | Office | 234 | 154 | $152.75 | $36K |
| 95720 Neurologic | Facility | 195 | 100 | $187.18 | $36K |
| 99213 Office E&M - Established | Office | 174 | 147 | $70.41 | $12K |
| 95816 Neurologic | Office | 141 | 140 | $340.88 | $48K |
| 95970 Electrical Nerve Conductivity | Office | 75 | 46 | $16.05 | $1,204 |
| 99233 Hospital E&M - Subsequent | Facility | 74 | 27 | $107.59 | $7,962 |
| 95819 Neurologic | Office | 62 | 61 | $424.10 | $26K |
| 95700 Neurologic | Office | 45 | 43 | $219.30 | $9,869 |
| 99232 Hospital E&M - Subsequent | Facility | 41 | 18 | $71.66 | $2,938 |
| 99223 Hospital E&M - Initial | Facility | 39 | 37 | $157.17 | $6,130 |
| 95708 Neurologic | Office | 38 | 25 | $129.85 | $4,934 |
| 99310 SNF E&M | Office | 37 | 21 | $135.54 | $5,015 |
| 99231 Hospital E&M - Subsequent | Facility | 35 | 11 | $44.71 | $1,565 |
By year: 2022 $271K for 2,120 services; 2023 $234K for 1,825 services; 2024 $284K for 2,266 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eric B Geller prescribed most often to Medicare patients was Lamotrigine, with 1,158 prescriptions and refills. In total Eric B Geller wrote 8,437 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lamotrigine Generic | 1,158 | 2,052 | 173 | $22K |
| Levetiracetam Generic | 754 | 1,330 | 135 | $30K |
| Divalproex Sodium Er Divalproex Sodium | 506 | 798 | 65 | $28K |
| Topiramate Generic | 476 | 701 | 56 | $13K |
| Zonisamide Generic | 435 | 839 | 66 | $18K |
| Lacosamide Generic | 289 | 359 | 39 | $19K |
| Lorazepam Generic | 277 | 286 | 77 | $1,206 |
| Xcopri Cenobamate | 266 | 304 | 21 | $378K |
| Clonazepam Generic | 210 | 250 | 55 | $2,881 |
| Phenobarbital Generic | 201 | 228 | 19 | $3,976 |
| Briviact Brivaracetam | 172 | 221 | 20 | $341K |
| Lamotrigine Er Lamotrigine | 164 | 333 | 28 | $74K |
| Oxcarbazepine Generic | 154 | 221 | 22 | $14K |
| Gabapentin Generic | 149 | 210 | 27 | $2,172 |
| Levetiracetam Er Levetiracetam | 148 | 301 | 29 | $11K |
Brand drugs: 1,502 claims; generic drugs: 6,734 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eric B Geller $453 ($453 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $144.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.